Biochemical Reagent
-
BA8886 BPI-9016MSummary: BPI-9016M is a potent, orally active, selective dual and tyrosine kinase inhibitor. - BA8887 JNJ-38877618Summary: JNJ-38877618 is an effective.
- BA8888 SYN1143Summary: SYN1143 is a potent, selective and orally active dual inhibitor.
- BA8889 BAY-474Summary: BAY-474 is a tyrosine protein kinase inhibitor.
- BA8890 DalmelitinibSummary: Dalmelitinib is an orally active kinase-selective inhibitor that binds to the ATP-binding region of c-Met.
- BA8891 GemnelatinibSummary: Gemnelatinib is an inhibitor.
- BA8892 CanlitinibSummary: Canlitinib is a tyrosine kinase inhibitor.
- BA8893 LMTK3-IN-1Summary: LMTK3-IN-1 is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (=2.5 μM) and acts through the ubiquitin proteasome pathway to degrade LMTK3.
- BA8894 EmzeltrectinibSummary: Emzeltrectinib is a potent tyrosine kinase inhibitor.
- BA8895 AdrixetinibSummary: Adrixetinib is a protein tyrosine kinase inhibitor.